Skip to main content
Premium Trial:

Request an Annual Quote

Andrea Grant and Helmuth van Es

Premium

Galapagos Genomics said that Andrea Grant, its director of business development, has been named the managing director of the company’s new discovery and validation business unit Galadeno.

Grant joined Galapagos in 2003 from the healthcare practice Cambridge Consultants, where she was a senior consultant. Prior to this, she was commercial director at Incyte Genomics. According to Galapagos, she has also works as a senior scientist at Glaxo Wellcome, and holds a PhD in molecular medicine from Cambridge University.

Also joining Galadeno is Galapagos co-founder Helmuth van Es, who will be the new unit’s chief scientific officer. Van Es previously was a group leader at IntroGene, which is now Crucell, and holds a PhD from the University of Amsterdam, according to Galapagos.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.